Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating idasanutlin in combination with cytarabine and daunorubicin in newly diagnosed AML and maintenance in first remission; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Idasanutlin (Idasanutlin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-06-21